Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA7 | P43166 | 4/20 | 0.42 |
| ▸ | CA9 | Q16790 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1064932 | 0.78 | GFER (0.42) | CA1CA7CA9CA12CA2 | |
| SCHEMBL29154360 | 0.75 | GRIN2D (0.43) | CA1CA7CA9CA12CA2 | |
| SCHEMBL6854794 | 0.72 | ALOX5 (0.37) | CA1CA7CA9CA12CA2 | |
| SCHEMBL11862521 | 0.71 | CA12 (0.43) | CA1CA7CA9CA12CA2 | |
| SCHEMBL7647130 | 0.70 | CA12 (0.42) | CA1CA7CA9CA12CA2 | |
| SCHEMBL3226561 | 0.68 | S100A4 (0.39) | ALDH1A1HPGDCYP1A2LMNAPOLB | |
| SCHEMBL3228155 | 0.68 | KDM4E (0.35) | CA1CA7CA9CA2CA14 | |
| SCHEMBL382451 | 0.68 | NPC1 (0.35) | ALDH1A1HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6345650 | 0.68 | PARP1 (0.33) | CASP3PDE3BPDE3A | |
| SCHEMBL3795668 | 0.68 | TERT (0.42) | ALDH1A1KDM4EHPGDSMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107188771-B | Chiral synthesis method of gamma-nitrophenol compound | 浙江工业大学 | 2021-08-24 | — | — | CN | claimed |
| CN-120463725-A | Double-cavity tetraimidazolium cyclotomato, and preparation method and application thereof | 延安大学 | 2025-08-12 | — | — | CN | disclosed |
| CN-107188771-B | Chiral synthesis method of gamma-nitrophenol compound | 浙江工业大学 | 2021-08-24 | — | — | CN | disclosed |
| EP-2290015-B1 | NANOSCALE PIGMENT PARTICLE COMPOSITION AND PROCESS FOR PRODUCING THE SAME | XEROX CORP (US) | 2017-05-24 | — | — | EP | disclosed |
| EP-2290013-B1 | METHODS OF MAKING NANAOSIZED PARTICLES OF BENZOIMIDAZOLONE PIGMENTS | XEROX CORP (US) | 2017-03-29 | — | — | EP | disclosed |
| US-9035287-B2 | Polymeric materials for use in metal-oxide-semiconductor field-effect transistors | POLYERA CORPORATION (US) | 2015-05-19 | — | — | US | disclosed |
| US-20140217395-A1 | Polymeric Materials for Use in Metal-Oxide-Semiconductor Field-Effect Transistors | POLYERA CORPORATION (US) | 2014-08-07 | — | — | US | disclosed |
| US-20130303516-A1 | NOVEL TRIAZINE COMPOUNDS | SPHAERA PHARMA PTE. LTD. (SG) | 2013-11-14 | — | — | US | disclosed |
| US-8461351-B2 | Sterically bulky stabilizers | XEROX CORPORATION (US) | 2013-06-11 | — | — | US | disclosed |
| US-8362270-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2013-01-29 | — | — | US | disclosed |
| EP-2290013-A2 | Methods of making nanosized particles of benzimidazolone pigments | Xerox Corporation (US) | 2011-03-02 | — | — | EP | disclosed |
| US-7883574-B2 | Methods of making nanosized particles of benzimidazolone pigments | XEROX CORPORATION (US) | 2011-02-08 | — | — | US | disclosed |
| US-20100300326-A1 | NONPOLAR LIQUID AND SOLID PHASE CHANGE INK COMPOSITIONS COMPRISING NANOSIZED PARTICLES OF BENZIMIDAZOLONE PIGMENTS | XEROX CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| WO-2010015037-A1 | THERAPEUTIC METHODS AND COMPOSITIONS | HOWARD FLOREY INSTITUTE (AU) | 2010-02-11 | — | — | WO | disclosed |
| US-20100035172-A1 | NANOSIZED PARTICLES OF BENZIMIDAZOLONE PIGMENTS | XEROX CORPORATION (US) | 2010-02-11 | — | — | US | disclosed |
| US-20100004360-A1 | METHODS OF MAKING NANOSIZED PARTICLES OF BENZIMIDAZOLONE PIGMENTS | XEROX CORPORATION (US) | 2010-01-07 | — | — | US | disclosed |
| EP-0355024-B1 | PROCESS FOR THE PRODUCTION OF CYCLIC UREAS | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-09-15 | — | — | EP | disclosed |
| US-4987234-A | AROMATIC ORTHO-DIAMINE AND CARBON DIOXIDE IN WATER; HIGH YIELD | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-01-22 | — | — | US | disclosed |
| EP-0355024-A1 | Process for the production of cyclic ureas | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-02-21 | — | — | EP | disclosed |
| US-4367337-A | Process for conversion of benzimidazolones to benzotriazoles | THE SHERWIN-WILLIAMS COMPANY (US) | 1983-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303516-A1 | NOVEL TRIAZINE COMPOUNDS | MTOR, MAPKAP1, PIK3R5 | CA1 4784/4885CA7 4349/4885CA9 4666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.